SMO and chronic myelogenous leukemia, BCR-ABL1 positive: Moreover, activation of the Hh stem cell pathway agonist, smoothened (SMO) and downstream glioma associated (GLI) zinc finger transcriptional regulators, promoted LSC maintenance in a mouse model of CML [17].